Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer
- P. Ramirez, M. Frumovitz, +17 authors A. Obermair
- The New England journal of medicine
- 31 October 2018
In this trial, minimally invasive radical hysterectomy was associated with lower rates of disease‐free survival and overall survival than open abdominal radical hysteresis among women with early‐stage cervical cancer. Expand
Quality of life and sexual functioning in cervical cancer survivors.
- M. Frumovitz, Charlotte C. Sun, +8 authors D. Bodurka
- Journal of clinical oncology : official journal…
- 20 October 2005
Cervical cancer survivors treated with radiotherapy had worse sexual functioning than did those treated with radical hysterectomy and lymph node dissection, and data suggest that cervical cancer survivorstreated with surgery alone can expect overall quality of life and sexual function not unlike that of peers without a history of cancer. Expand
Patterns of Gene Expression in Different Histotypes of Epithelial Ovarian Cancer Correlate with Those in Normal Fallopian Tube, Endometrium, and Colon
Studies at a molecular level show distinct expression profiles of different histologies of ovarian cancer and support the long-held belief that histotypes of ovarian cancers come to resemble normal fallopian tube, endometrial, and colonic epithelium. Expand
Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma.
Pretherapeutic laparoscopic assessment of patients with locally advanced cervical cancer offers valuable information for individualized treatment planning with minimal morbidity with therapeutic effect with resection of positive nodes followed by a tailored chemoradiation therapy. Expand
Are women ready for the HPV vaccine?
A willingness of women to accept the HPV vaccine for themselves and their children was demonstrated in a pilot study that demonstrated a willingness to reduce the incidence of cervical cancer. Expand
COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers
- P. Ramirez, L. Chiva, +5 authors R. Pareja
- International Journal of Gynecological Cancer
- 27 March 2020
The Editorial Team of the International Journal of Gynecological Cancer have compiled evidence-based data using established guidelines to propose strategies to optimize care of patients while at the same time offering potential options to alleviate the burden to the healthcare system when resources may need to be diverted to the direct care of Patients affected by the coronavirus (COVID-19) disease. Expand
Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.
- P. Ramirez, M. Frumovitz, D. Bodurka, Charlotte C. Sun, C. Levenback
- Gynecologic oncology
- 1 October 2004
The majority of patients reported with well-differentiated endometrial adenocarcinoma who undergo conservative treatment with a progestational agent respond to treatment, and carcinoma extending beyond the uterus is rare. Expand
Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer.
Subserosal fundal injection of blue dye and the radiocolloid is a poor technique for identifying sentinel lymph nodes in patients with high-risk endometrial cancer. Expand
Parametrial Involvement in Radical Hysterectomy Specimens for Women With Early-Stage Cervical Cancer
If prospective application of these findings confirms the results, less radical surgery—such as simple hysterectomy, simple trachelectomy, or conization—with pelvic lymphadenectomy may be a reasonable therapeutic option for women with primary tumors 2 cm or smaller and no lymphovascular space invasion. Expand
Mucinous Tumors of the Ovary: Current Thoughts on Diagnosis and Management
A continuum appears to be present from benign to borderline to malignant, which is different from other types of epithelial ovarian cancer, and characteristics lead to specific biologic behavior and guide both clinical management and research efforts in patients with mucinous ovarian tumors. Expand